Unique initiative with private practitioners against MDR-TB in India

 

REACH logoLilly logoKNCV_ENG-2015-FC

EQUIP project REACH Chennai India, DOT supervisor Joseph - Photo Netty Kamp
EQUIP project, Chennai, India. DOT Supervisor Joseph Soundararaj. Photo by Netty Kamp

Private practitioners central to unique partnership against drug-resistant TB in Chennai, India.

The fight for a TB-free India continues to gain ground with the launch of an innovative project in the city of Chennai. Patients of private health practitioners are being offered rapid, accurate diagnosis for TB and drug-resistant TB through the project EQUIP. A public-private partnership is being created to ensure that private sector health providers and their patients will have free access to TB testing with the latest technology.

EQUIP seeks to demonstrate that the private sector in India can be a big part of the solution for a TB-Free India. The Lilly MDR-TB Partnership, KNCV Tuberculosis Foundation, and local non-governmental organization REACH (Resource Group for Education and Advocacy for Community Health) are joining forces with India’s TB control program (RNTCP) in this unique collaboration.

Through EQUIP we are creating a public-private partnership to ensure that private sector health providers and their patients have free access to the new GeneXpert laboratory test for early diagnosis of TB and the detection of TB drug-resistance. This means that we can save more lives and prevent others from becoming infected. This is the first time that a collaboration with the private sector has focused specifically on the growing problem of multidrug-resistant TB (MDR-TB) in India.

See also the guest blog by Agnes Gebhard about KNCV’s partnership with Lilly in the MDR-TB Partnership.

Read more

Photo © Netty Kamp: Laboratory staff of the PPM center at the Hindu Welfare Hospital in Central Chennai.
Laboratory staff at PPM center, Hindu Welfare Hospital in Central Chennai, participating in EQUIP project REACH. Photo by Netty Kamp.

 

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

Address

KNCV Tuberculosefonds
Maanweg 174
2516 AB Den Haag
+31 70 416 7222

OPEN IN GOOGLE MAPS

Postal address

Postbus 146
2501 CC Den Haag

More information

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.